PharVision Advisers’s Fox Class A FOXA Stock Holding History

PharVision Advisers’s Portfolio FOXA Stock Details FOXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,337	Closed	-$502K	–	356
2024 Q4	$502K	Buy	+10,337	New	+$466K	0.42%	41

Other funds holding FOXA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's FOXA Position: Q1 2025 in Review

PharVision Advisers sold out of Fox Class A (FOXA) in Q1 2025, closing a stake of 10,337 shares — an estimated $502K sold.

PharVision Advisers first reported a position in FOXA in Q4 2024 and held it in 1 quarter. The position peaked at $502K in Q4 2024. 678 funds tracked by Wall St. Rank hold FOXA as of Q1 2025.

PharVision Advisers reported no remaining Fox Class A position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 10,337 Fox Class A shares in Q1 2025, an estimated $502K.
PharVision Advisers first reported a position in Fox Class A in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Fox Class A position peaked at $502K in Q4 2024.
678 funds tracked by Wall St. Rank held Fox Class A as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.